Editas Medicine, Inc. Common Stock (EDIT) is a publicly traded Healthcare sector company. As of August 19, 2026, EDIT trades at $2.88 with a market cap of $436.17M and a P/E ratio of -4.17. EDIT moved +1.41% today. Year to date, EDIT is +40.49%; over the trailing twelve months it is +5.49%. Its 52-week range spans $0.91 to $4.54. Analyst consensus is buy with an average price target of $8.00. Rallies surfaces EDIT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
6 analysts cover EDIT: 0 strong buy, 4 buy, 1 hold, 1 sell, and 0 strong sell. The consensus rating is buy. The average price target is $8.00.
| Metric | Value |
|---|---|
| Price | $2.88 |
| Market Cap | $436.17M |
| P/E Ratio | -4.17 |
| EPS | $-0.68 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.54 |
| 52-Week Low | $0.91 |
| Volume | 2.09M |
| Avg Volume | 0 |
| Revenue (TTM) | $47.01M |
| Net Income | $-73.95M |
| Gross Margin | 0.00% |
6 analysts cover EDIT: 0 strong buy, 4 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.00.